Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome

Pre-clinical studies provide compelling evidence that Eph family receptor tyrosine kinases (RTKs) and ligands promote cancer growth, neovascularization, invasion, and metastasis. Tumor suppressive roles have also been reported for the receptors, however, creating a potential barrier for clinical app...

Ausführliche Beschreibung